Work

Response to rethinking Alzheimer's disease susceptibility and heterogeneity. Comment on Miller et al

Year: 2026

Type: article

Abstract: Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Source: Alzheimer s & Dementia

DOI: 10.1002/alz.71454

Authors: Zachary A. Miller, Bruce L. Miller, Gil D. Rabinovici, Maria Luisa Gorno‐Tempini

Institution: University of California, San Francisco

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,200

Funders: National Institutes of Health, Genentech, Johnson and Johnson, GE Healthcare, National Institute on Aging, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke

Awards: G1611992435, G1853415910, G1888650583, Early Age-of-Onset AD: Clinical Heterogeneity and Network Degeneration, G6348851466, G816726602, G8498316205, Frontotemporal Dementia: Genes, Images, and Emotions, Training program in the neurology of language and neurodegenerative aphasias, G963519774

OpenAlex ID: W7160776409

FWCI:

Cites: 2

Cited by:

Related to: